David Angulo

Affiliations

SCYNEXIS, Inc., Jersey City, New Jersey, USA.

Publications (3)

Activity of a novel 1,3-beta-D-glucan Synthase Inhibitor, Ibrexafungerp (formerly SCY-078), Against

Antimicrobial agents and chemotherapy

Avec: M Ghannoum , L Long , N Isham , C Hager , R Wilson , K Borroto-Esoda , S Barat , D Angulo

A Novel 1,3-Beta-d-Glucan Inhibitor, Ibrexafungerp (Formerly SCY-078), Shows Potent Activity in the Lower pH Environment of Vulvovaginitis.

Antimicrobial agents and chemotherapy

Avec: E L Larkin , L Long , N Isham , K Borroto-Esoda , S Barat , D Angulo , S Wring , M Ghannoum

Antimicrobial agents and chemotherapy

Avec: Jack D Sobel , Katyna Borroto-Esoda , Nkechi Azie , David Angulo

Réseau de co-auteurs

M Ghannoum 2 collaborations

L Long 2 collaborations

N Isham 2 collaborations

K Borroto-Esoda 2 collaborations

S Barat 2 collaborations

D Angulo 2 collaborations

C Hager 1 collaboration

R Wilson 1 collaboration

E L Larkin 1 collaboration

S Wring 1 collaboration

Jack D Sobel 1 collaboration

Katyna Borroto-Esoda 1 collaboration

Nkechi Azie 1 collaboration